Dxylose Testing.docx
《Dxylose Testing.docx》由会员分享,可在线阅读,更多相关《Dxylose Testing.docx(16页珍藏版)》请在冰豆网上搜索。
DxyloseTesting
D-xyloseTesting
ournalofClinicalGastroenterology
Issue:
Volume29
(2), September1999, pp143-150
Craig,RobertM.M.D.;Ehrenpreis,EliD.M.D.
AuthorInformation
FromtheDivisionofGastroenterology/Hepatology(R.M.C.),DepartmentofMedicine,NorthwesternUniversityMedicalSchool,Chicago,IL;andtheDivisionofGastroenterology(E.D.E.),DepartmentofMedicine,UniversityofChicagoMedicalSchool,IL.
AddresscorrespondencestoDr.RobertM.Craig,NorthwesternUniversityMedicalSchool,Searle10-541,303E.Chicago,Chicago,IL60611.
Abstract
TheliteratureonD-xylosetestinghasbeenreviewed,stressingadvancesinourunderstandingofabsorptioningeneral(includingD-xyloseabsorption),therelationshipofD-xylosetestingtothedevelopmentofexcellentserologictestsforthediagnosisofceliacdisease,theuseofD-xylosetestingintheevaluationofdiarrheainacquiredimmunodeficiencysyndrome,newinformationonbreathtestingfortheevaluationofmalabsorption,andrecentinformationontheunderstandingofD-xyloseabsorptioncomparedwithtranscellularvs.paracellulartransport.TheauthorssuggestwaysinwhichD-xylosetestingmightbeemployedinmalabsorptionordiarrheaevaluations,includingsomealgorithms.
SinceourlastreviewonD-xylosetesting,1 therehavebeenadvancesinourunderstandingofabsorptioningeneral,includingD-xyloseabsorption,thedevelopmentofexcellentserologictestsforthediagnosisofceliacdisease,theuseofD-xylosetestingintheevaluationofdiarrheainacquiredimmunodeficiencysyndrome(AIDS),newinformationonbreathtestingfortheevaluationofmalabsorption,andnewinformationontheunderstandingofD-xyloseabsorptioncomparedwithtranscellularvs.paracellulartransit.WehavereviewedtheliteratureonD-xylosetestingandrelatepastunderstandingtothenewerdevelopments.
BacktoTop
PHYSIOLOGY,CHEMISTRY,ANDKINETICSOFABSORPTION
D-xyloseisapentosefoundnaturallyinplants.2 Itsincompleteabsorptionallowsittobeusedasanabsorptivetest.Othermonosaccharidesareabsorbedmuchmoreavidly,evenwhenthesmallintestineisabnormal.3 Itisabsorbedunchangedfromthesmallintestine,4,5 andapproximately30%ismetabolizedbythelivertocarbondioxide(CO2)andthreitol.6,7 Inaddition,5%oftheabsorbeddoseisexcretedunchangedinthebileandundergoesenterohepaticcycling.8Theremainderisexcretedintheurine,allowingforitsuseinclinicaltesting.
RecentlywehaveusedakineticmodelofD-xyloseabsorptioninanattempttocharacterizesmallbowelabsorptionphysiologically (Fig.1).9-15 Byusingintravenousandoraldosingfollowedbyfrequentsamplingofthebloodandurine,weareabletoshowthatD-xyloseisdistributedprimarilyintheextracellularspace.Approximatelyhalfoftheintravenouslyadministereddoseisexcretedbythekidneys,andtheremaininghalfisexcretedbynonrenal,presumablyhepatic,mechanisms.Withthedeconvolutionoftheoraldosingcurve,utilizingthedistributionandexcretioncharacteristicsfromtheintravenouscurve,wecancharacterizetheabsorptionkineticsintermsofrateconstants:
Ka,theabsorptionconstantforD-xyloseabsorption,andKo,thekineticparameterfornonabsorptivegastrointestinallosses.ThebioavailabilityofD-xylosecanbecalculatedbytheratioofKa/Ka+Ko.Normalsubjectsabsorbapproximately70%ofa25-goraldose.9 WefoundthatKacorrelatescloselywiththe1-hourserumconcentrationofD-xylose(r =0.74, p =5.0×10-4),andthatthe5-hoururinecontentofD-xylosecorrelatescloselywithitsabsolutebioavailability,F(r =0.93,p <1×10-6).11
Fig.1
Innormalindividualsapproximately70%absorptionofa25-gdose,withapproximately50%renalexcretion,yields8.75grenalexcretion,puttingitintherangeofnormal5-hoururinaryD-xylosecontentafter25-gdosing.Essentiallyalloftheabsorption,metabolism,andexcretionoccurwithinthefirst5hoursafteradministration.11 Theacceptedlowerlimitofnormalforthe5-hoururinecontentinpatientswithnormalrenalfunctionis4g.11 Theacceptedlowerlimitofnormalforthe1-hourserumD-xyloseconcentrationforthosewithcreatinineclearancegreaterthan30mL/minis25mg/dL.9-11
ThemechanismofD-xyloseenterocyteabsorptioniscontroversial.StudiesinnormalmicrovillousvesiclessupportpassiveabsorptionasthepredominantmechanismofD-xyloseabsorption.16 Inaddition,intestinalperfusionstudiesinnormalhumanshaveshownthatD-xyloseisabsorbedpassively,althoughtheconcentrationsemployedinthesestudieswerelowerthanthoseusedinstandardD-xylosetesting.16 Asaturableelementmayhavebeenobservedwithhigherconcentrations.Earlierintestinalperfusionstudiesalsosuggestedasmall,saturablecomponenttoD-xyloseabsorption.5 PassiveabsorptionofD-xylosedoesnotdependoncarrier-mediatedMichaelis-Mentonkinetics,andtherateconstantforabsorptionshouldnotchangewithdifferentdosesofD-xylose.ThekineticsofD-xyloseabsorptionforthe25-and15-gdosesinpatients,mostlywithsmallintestinalmalabsorption,havebeencompared.12 Therateconstantforabsorption,Ka,wasslightlyhigherinthosewiththelowerdose,suggestingsomecomponentofactiveabsorption.However,thesedataoverallsupportpredominantlypassiveabsorption-transcellularorparacellular-withlittleornocarrier-mediatedtransport.AlthoughdatahavebeenpublishedwithvaryingdosesofD-xylose,thereareonlyformalkineticstudieswiththe25-and15-gdoses.9-15Thesesupporttheclinicalutilityofthelowerlimitofnormalforthe5-hoururineD-xylosecontentinpatientswithnormalrenalfunctionof4gforthe25-gdoseand2.5gforthe15-gdose;andthelowerlimitofnormalforthe1-hourserumD-xyloseof25mg/dLforeitherthe25-or15-gdoseforpatientswithcreatinineclearance>30mL/min.10,12 Preliminarydatainourlaboratoryshowthatthe15-gdosemaybeusedinanephricpatientsandthatthelowerlimitofnormalforthe1-hourserumD-xyloseconcentrationis20mg/dL(R.M.Craig,unpublishedobservations).
BacktoTop
USEOFD-XYLOSETESTINGINPEDIATRICS,GERIATRICS,ANDVARIOUSDISEASESTATES
TheuseofserumratherthanurinaryD-xylosetestinginpediatricsisfavoredduetodifficultiesinobtainingaccuratelytimedurinecollections,especiallyinveryyoungchildrenandinfants.17,18 BecauseD-xyloseabsorptionandexcretionincreaseduringthefirstyearoflife,19,20 somemodificationofnormallevelsisrequired.Forchildrenlessthan12yearsold,wehavesuggestedthatalowerlimitofnormalforthe1-hourserumD-xyloseconcentrationshouldbe15mg/dLaftera5-gdose.1 Usingadoseof15g/m2 forinfantsorchildrenlessthan6monthsofageisappropriate,withthelowerlimitofnormalagainbeing15mg/dL.21-23
SomestudieshaveindicatedthataserumendomysialantibodyismoresensitiveandspecificthaneithertheserumorurineD-xylosetestindiagnosingceliacdiseaseinchildren.24 Othershavereportedonlya67%predictionaccuracyofD-xylosetestingininfantswithbiopsy-provedduodenalatrophy.25 AnovelironabsorptiontesthasalsobeenshowntobesuperiortotheD-xylosetestinonegroupofchildrenwithceliacdiseaseandothersmallintestinalabsorptivedefects.26
ThereisapparentlynoinherentdiminutioninD-xyloseabsorptionintheelderlyifrenalfunctionisaddressedappropriately.27-29 Thishasalsobeenconfirmedwithpharmacokineticanalysisinelderlypatients.30,31
AppropriatetestingconditionsarerequiredbecauseseveralfactorsmayaltertheinterpretationofD-xylosetesting.Thetestingshouldbedonefastingbecausetheremaybeacomponentoffacilitatedabsorptionfromglucose,andmeatorfibermightdiminishD-xyloseabsorption.32,33 Prokineticandantimotilityagentsshouldprobablybeavoidedaswell.
Thevalueofcombiningthe1-hourserumconcentrationandthe5-hoururinecontentofD-xyloseisunderscoredbytheexamplesofdelayedgastricemptyingandintestinalhurry.IntestinalhurrymightdiminishbioavailabilityofD-xylose,reflectedclinicallyinalowerthanexpected5-hoururinaryD-xylosetest.Thisobservationisconfirmedbythedecreasedbioavailabilityseenwiththe25-gdoseoverthe15-gdose,9,12 presumablyduetoosmoticeffectsfromthelargerdose.However,the1-hourserumD-xylose(ortherateconstantforabsorption)isnotaffectedsignificantlybyamodifieddose,9,12 andwillbenormalinpatientswithdiarrheadueonlytointestinalhurry.
Diminishedgastricemptyingmightbeexpectedtoyieldalow1-hourserumD-xyloseandadiminishedrateconstantforabsorption,Ka.34 However,thebioavailabilitymightstillbenormal,unlesstheD-xyloseneverleavesthestomach.Thenormalbioavailabilityunderthesecircumstanceswouldbereflectedclinicallyinanormal5-hoururinaryD-xylosecontent.
PortalhypertensionwouldbeexpectedtobeassociatedwithdiminishedD-xylosebioavailabilityduetosplanchniccongestion,asseeninonestudyindogs.35 However,theremightbediminishedhepaticmetabolismduetoshuntingaroundtheliverordecreasedhepaticfunction,yieldinghigherthanexpectedurinaryorserumvalues.Onestudyof25cirrhoticpatientsshowednormalD-xyloseabsorption.36 DiminishedexcretionofD-xylosemightbeexpectedwiththepresenceofascitesbecauseD-xyloseisdistributedininterstitialspace,includingascites.37 FormalkineticevaluationsofD-xylosedistributionandabsorptionhavenotbeenperformedinthispatientgroup.
TherearesomedatathatindicatethediminishedexcretionorabsorptionofD-xylosemightensuefromtheuseofnonsteroidalanti-inflammatoryagentsoraspirin,38 and